NASD · Healthcare · Biotechnology · USA
PepGen Inc is a micro cap company (market value under $300 million) in the Biotechnology industry.
PepGen Inc is a clinical-stage biotechnology company developing oligonucleotide therapeutics using its proprietary Enhanced Delivery Oligonucleotide platform, which leverages cell-penetrating peptides to improve drug uptake and activity in target tissues. The company is developing PGN-EDODM1 for treating myotonic dystrophy, a severe neuromuscular disease.
From its FY2025 annual report (Form 10-K)
Intrinsic value, DCF valuation, financial health and value investing analysis for the PepGen Inc stock.
Not valued: We cannot value this company yet.
3 more funds hold it; the full list is part of the paid plan.
129 more in this industry show a wider margin of safety.
We do not publish a verdict on PEPG yet. We are missing a figure this valuation depends on. We would rather say so than show a number built on a guess.
We do not publish one (as of the 2026-11-17 close). We are missing a figure this valuation depends on. We would rather say so than show a number built on a guess.